BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32313192)

  • 1. Adherence to antihypertensive medication and its predictors among non-elderly adults in Japan.
    Nishimura S; Kumamaru H; Shoji S; Sawano M; Kohsaka S; Miyata H
    Hypertens Res; 2020 Jul; 43(7):705-714. PubMed ID: 32313192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the LIFE study.
    Sagara K; Goto K; Maeda M; Murata F; Fukuda H
    J Hypertens; 2024 Apr; 42(4):718-726. PubMed ID: 38230627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.
    Ishida T; Oh A; Hiroi S; Shimasaki Y; Nishigaki N; Tsuchihashi T
    Hypertens Res; 2019 Feb; 42(2):249-256. PubMed ID: 30443023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence with antihypertensives in uncomplicated treatment-naïve very elderly patients: a nationwide population-based study.
    Choi KH; Yu YM; Ah YM; Chang MJ; Lee JY
    BMC Cardiovasc Disord; 2017 Aug; 17(1):232. PubMed ID: 28836946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice.
    Corrao G; Rea F; Ghirardi A; Soranna D; Merlino L; Mancia G
    Hypertension; 2015 Oct; 66(4):742-9. PubMed ID: 26222709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication adherence to first-line antihypertensive drug class in a large Chinese population.
    Wong MC; Tam WW; Cheung CS; Tong EL; Sek AC; Cheung NT; Leeder S; Griffiths S
    Int J Cardiol; 2013 Aug; 167(4):1438-42. PubMed ID: 22560948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
    Schulz M; Krueger K; Schuessel K; Friedland K; Laufs U; Mueller WE; Ude M
    Int J Cardiol; 2016 Oct; 220():668-76. PubMed ID: 27393848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive Medication Nonpersistence and Low Adherence for Adults <65 Years Initiating Treatment in 2007-2014.
    Tajeu GS; Kent ST; Huang L; Bress AP; Cuffee Y; Halpern MT; Kronish IM; Krousel-Wood M; Mefford MT; Shimbo D; Muntner P
    Hypertension; 2019 Jul; 74(1):35-46. PubMed ID: 31132956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
    Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
    Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
    Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA;
    Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study.
    Verma AA; Khuu W; Tadrous M; Gomes T; Mamdani MM
    PLoS Med; 2018 Jun; 15(6):e1002584. PubMed ID: 29889841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.
    Després F; Perreault S; Lalonde L; Forget A; Kettani FZ; Blais L
    Can J Cardiol; 2014 May; 30(5):560-7. PubMed ID: 24613090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition probabilities and predictors of adherence in a California Medicaid population using antihypertensive and lipid-lowering medications.
    Nichol MB; Knight TK; Wu J; Tang SS; Cherry SB; Benner JS; Hussein M
    Value Health; 2009 Jun; 12(4):544-50. PubMed ID: 19138308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
    BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring factors associated with patients' adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom.
    Kurdi AI; Chen LC; Elliott RA
    J Hypertens; 2017 Sep; 35(9):1881-1890. PubMed ID: 28441185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive treatment for hypertensive patients with heart failure using real-world Japanese data: subanalysis of the Retrospective study of antihypertensives for lowering blood pressure (REAL) study.
    Ohishi M; Yoshida T; Nishigaki N; Oh A; Shimasaki Y
    Clin Exp Hypertens; 2020; 42(2):139-145. PubMed ID: 30912679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
    Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.